Annual CFO
-$11.71 M
-$1.61 M-16.00%
December 1, 2022
Summary
- As of March 13, 2025, CERO annual cash flow from operations is -$11.71 million, with the most recent change of -$1.61 million (-16.00%) on December 1, 2022.
- During the last 3 years, CERO annual CFO has fallen by -$1.61 million (-16.00%).
- CERO annual CFO is now -16.00% below its all-time high of -$10.09 million, reached on December 1, 2021.
Performance
CERO Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFO
N/A
September 1, 2024
Summary
- CERO quarterly cash flow from operations is not available.
Performance
CERO Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM CFO
N/A
September 1, 2024
Summary
- CERO TTM cash flow from operations is not available.
Performance
CERO TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
CERO Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -16.0% | - | - |
| 3 y3 years | -16.0% | - | - |
| 5 y5 years | -16.0% | - | - |
CERO Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -16.0% | at low | ||||
| 5 y | 5-year | -16.0% | at low | ||||
| alltime | all time | -16.0% | at low |
CERo Therapeutics Holdings Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2023 | - | -$1.32 M(-36.4%) | -$4.83 M(+37.5%) |
| Jun 2023 | - | -$2.07 M(+44.4%) | -$3.51 M(+144.4%) |
| Mar 2023 | - | -$1.44 M | -$1.44 M |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2022 | -$11.71 M(+16.0%) | - | - |
| Mar 2022 | - | -$3.79 M | -$3.79 M |
| Dec 2021 | -$10.09 M | - | - |
FAQ
- What is CERo Therapeutics Holdings annual cash flow from operations?
- What is the all time high annual CFO for CERo Therapeutics Holdings?
- What is CERo Therapeutics Holdings annual CFO year-on-year change?
- What is the all time high quarterly CFO for CERo Therapeutics Holdings?
- What is the all time high TTM CFO for CERo Therapeutics Holdings?
What is CERo Therapeutics Holdings annual cash flow from operations?
The current annual CFO of CERO is -$11.71 M
What is the all time high annual CFO for CERo Therapeutics Holdings?
CERo Therapeutics Holdings all-time high annual cash flow from operations is -$10.09 M
What is CERo Therapeutics Holdings annual CFO year-on-year change?
Over the past year, CERO annual cash flow from operations has changed by -$1.61 M (-16.00%)
What is the all time high quarterly CFO for CERo Therapeutics Holdings?
CERo Therapeutics Holdings all-time high quarterly cash flow from operations is -$1.32 M
What is the all time high TTM CFO for CERo Therapeutics Holdings?
CERo Therapeutics Holdings all-time high TTM cash flow from operations is -$1.44 M